ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026
Go back to ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026| ORION MARINE GROUP, Inc. (NYSE: ORN) | Delayed: 14.51 +0.46 (3.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.05 | 52 Week High | $9.48 | |||
| Open | $14.21 | 52 Week Low | $3.25 | |||
| Day High | $14.99 | P/E | N/A | |||
| Day Low | $14.05 | EPS | $-0.01 | |||
| Volume | 223,497 | |||||
